Immune thrombocytopenic purpura healing after removing cardiac thrombosis-Reference-Cited by-同舟云学术

Immune thrombocytopenic purpura healing after removing cardiac thrombosis

Published:2022-10-27 Issue:5 Volume:19 Page:48-50
ISSN:1812-2892
Container-title:Journal of Clinical Medicine of Kazakhstan
language:
Short-container-title:J CLIN MED KAZ

Author:

Topaloglu Omer¹^ORCID,Akdogan Ali²^ORCID,Ozdemir Ahmet Coskun¹^ORCID

Affiliation:

1. Department of Cardiovascular Surgery, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey

2. Department of Anaesthesiology and Intensive Care, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey

Abstract

Because of the rareness of the reports about immune thrombocytopenic purpura patients undergoing cardiac surgery, there is no sufficient knowledge about perioperative strategies. In this article, we report a 42-year-old female patient with severe mitral regurgitation and large right atrial thrombus, in whom thrombocytopenia had disappeared after mitral valve replacement and thrombectomy from the right atrium. Large thrombi should kept in mind as reason of thrombocytopenia.

Publisher

JSC National Scientific Medical Research Center

Subject

General Medicine

Link

https://www.clinmedkaz.org/download/immune-thrombocytopenic-purpura-healing-after-removing-cardiac-thrombosis-12506.pdf

Reference7 articles.

1. Abrahamson PE, Hall SA, Feudjo-Tepie M, Mitrani-Gold FS, Logie J. The incidence of idiopathic thrombocytopenic purpura among adults: a population-based study and literature review. Eur J Haematol. 2009;83(2):83-9. https://doi.org/10.1111/j.1600-0609.2009.01247.x

2. Köner O, Cetin G, Karaoğlu K, Seren S, Bakay C. Fresh whole blood and immunoglobulin permit coronary artery bypass graft surgery in patients with idiopathic thrombocytopenic purpura. J Cardiothorac Vasc Anesth. 2001;15(4):483-4. https://doi.org/10.1053/jcan.2001.25001

3. Christiansen S, Schmid C, Redmann K, Jahn UR, Stypmann J, Scheld HH, et al. Preoperative immunoglobulin treatment in patients with Werlhof's disease undergoing cardiac operation. Ann Thorac Surg. 2000;69(1):61-4. https://doi.org/10.1016/s0003-4975(99)01158-3

4. Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019;3(22):3780-3817. https://doi.org/10.1182/bloodadvances.2019000812

5. Aledort LM, Hayward CP, Chen MG, Nichol JL, Bussel J; ITP Study Group. Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies. Am J Hematol. 2004;76(3):205-13. https://doi.org/10.1002/ajh.20104